Overcoming Triple-Negative Breast Cancer
After her own fight against cancer, Melanie Nix works to help other breast cancer patients and advocates in support...
After her own fight against cancer, Melanie Nix works to help other breast cancer patients and advocates in support...
When Zach Witt’s cancer returned during standard treatment, his parents – John and Pam Witt – chose a trial...
Diagnosed with stage IV mucosal melanoma, Richard Murphy turned to clinical trials testing immunotherapy treatments after standard approaches failed. ...
For two-time cancer survivor Howard Brown, research provides hope while he lives with metastatic disease. Howard Brown is a...
After Her experience with colon cancer and a recurrence, Ashley says she is now celebrating Nine years cancer free....
Diagnosed with a rare form of ovarian cancer, Kimberly’s “whole world changed.” Kimberly Richardson of Chicago, an avid runner,...
Diagnosed with colorectal cancer at 32 years of age, Allison Rosen found meaning in helping others and advocating for...
I am a beautifully pale 27 year old who has Stage IV melanoma and is SURVIVING! I found out that...
I went for a physical just before my birthday in September 2013. As my doctor was palpitating my stomach...
Stunned to her core when she was diagnosed with the aggressive form of brain cancer, Shenell committed herself to...
Diagnosed with a rare and aggressive form of cancer—peritoneal mesothelioma—at the age of 21, Tamron shares her story to inspire...
Sarah Cauley was at her mother’s doctor’s office decades ago when a chance encounter and stomachache led to a...
To learn more about cancer prevention and risk reduction, we talked to Raymond N. DuBois, MD, PhD, FAACR, co-editor...
Study shines a light on the differences in outcomes between clinical trial patients with multiple myeloma and those receiving...
The second of a groundbreaking new type of immunotherapy called CAR T-cell therapy is approved for certain types of...
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
The FDA has approved an immunotherapeutic for certain patients with these cancers who had their cancer completely resected and...
Improvements in medical care have reduced the rate of relapse in acute myeloid leukemia after transplants, helped people live...
A new study found that a decrease in a specific population of circulating tumor cells over the first two...
The FDA approved pembrolizumab, in combination with chemotherapy, for certain patients with endometrial cancer. The U.S. Food and Drug...
Draft recommendation calls for screening at age 45, rather than 50. An influential panel of experts has issued a...
Despite concerns that reducing nicotine levels in cigarettes could have unintended effects on smoking behavior, findings from two recent...
The FDA recently approved the second cellular immunotherapy to treat certain adult patients with multiple myeloma. The U.S. Food...
The U.S. Food and Drug Administration has approved the first of a new type of immunotherapy called CAR T-cell...
The molecularly targeted therapeutic pexidartinib is the first ever systemic treatment approved by the FDA for the treatment of...
The FDA decision means tisagenlecleucel (Kymriah) is now approved for certain types of non-Hodgkin lymphoma and acute lymphoblastic leukemia....
Study: Thyroid cancer survivors – especially those diagnosed before age 40 – had elevated risk for several aging-related diseases....
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
Physicians consider which patients are ideal for immunotherapy drug combinations.
The CAR T-cell therapy is now approved for some patients with relapsed/refractory mantle cell lymphoma. The U.S. Food and...